| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |